Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 23, 2018 - The FDA announced that over-the-counter (OTC) benzocaine products should not be used to treat infants and children < 2 years of age.
Return to publications